Grant: Canada Research Chairs
University of Toronto
$120,000.00
Nucleic Acid Therapeutics
FY 2024-25
Summary
Complex diseases like cancer and arthritis are difficult to control because they are caused by multiple, interwoven biological processes. While some of these processes can be controlled by drugs, most remain difficult to manage. New engineering tools are needed to control disease on a grander scale. This program creates smart nanotechnology that delivers multiple instruction sets to cells via ribonucleic acid. The cells follow the instructions, which are designed to control these many intricate biological processes simultaneously. This smart nanotechnology will allow researcher to explore completely new areas of biology by offering a new, unprecedented level of control over diseases.
Program
Canada Research Chairs
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
CRC-2020-00097
Name nom
Khan, Omar
Department département
Institute of Biomedical Engineering - University of Toronto
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
120000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF20501; RDF20701
Field of research list names en
Chemical engineering;Medical and biomedical engineering
Field of research list names fr
Génie chimique;Génie médical et biomédical
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Nucleic Acid Therapeutics
Keywords
Nanomaterials; nanoparticles; biomaterials; nucleic acids; ribonucleic acids; controlled release; combinatorial chemistry; factorial design; disease mechanisms; screening; platform; delivery; total organic synthesis; formulation; production
Application summary
Complex diseases like cancer and arthritis are difficult to control because they are caused by multiple, interwoven biological processes. While some of these processes can be controlled by drugs, most remain difficult to manage. New engineering tools are needed to control disease on a grander scale. This program creates smart nanotechnology that delivers multiple instruction sets to cells via ribonucleic acid. The cells follow the instructions, which are designed to control these many intricate biological processes simultaneously. This smart nanotechnology will allow researcher to explore completely new areas of biology by offering a new, unprecedented level of control over diseases.